Lifeon Pharmaceutical: Obtained the drug registration certificate for Timolol Maleate Eye Drops

Lifeon Pharmaceutical announced that it has recently received the Drug Registration Certificate for Timolol Maleate Eye Drops issued by the National Medical Products Administration. This medication is an ophthalmic agent used to lower intraocular pressure and is suitable for the treatment of ocular hypertension and glaucoma. The Timolol Maleate Eye Drops for which the company has obtained the drug registration certificate are classified as Category 3 chemical drugs, with quality and efficacy consistent with the reference preparation. The production and sales of the drug may be affected by factors such as policies and market conditions, and there remains a certain degree of uncertainty